• 検索結果がありません。

Novel Osteoblast-Lineage Specific Cell-SurfaceAntigen Possibly Regulating Bone Remodeling andHard Tissue Regeneration

N/A
N/A
Protected

Academic year: 2021

シェア "Novel Osteoblast-Lineage Specific Cell-SurfaceAntigen Possibly Regulating Bone Remodeling andHard Tissue Regeneration"

Copied!
3
0
0

読み込み中.... (全文を見る)

全文

(1)

九州大学学術情報リポジトリ

Kyushu University Institutional Repository

Novel Osteoblast-Lineage Specific Cell-Surface Antigen Possibly Regulating Bone Remodeling and Hard Tissue Regeneration

タメール アブデルハイド アハメッド アブデルファッタ アハメッド バダ ウェイ

http://hdl.handle.net/2324/1959093

出版情報:九州大学, 2018, 博士(歯学), 課程博士 バージョン:

権利関係:やむを得ない事由により本文ファイル非公開 (3)

(2)

(様式3)

氏 名 :TAMER ABDELHADY AHMED ABDELFATTAH AHMED BADAWY

名 :

Novel Osteoblast-Lineage Specific Cell-Surface Antigen

Possibly Regulating Bone Remodeling and Hard Tissue Regeneration

(骨改造と硬組織再生を制御する新規骨芽細胞特異的細胞表面抗原に関す る研究)

区 分 :甲 Kou

論 文 内 容 の 要 旨

Bone remodeling is a dynamic lifelong process involving precisely coordinated interactions between various bone cells in distinct multi-cellular units. Osteoclasts, specialized multinucleated bone resorbing cells, play a pivotal role in bone remodeling. Although RANKL/RANK axis is considered to determine the gross number of osteoclasts present in bone tissues, detailed molecular events regulating bone remodeling related to sites of osteoclast appearance to initiate bone remodeling and coupling of bone resorption and bone formation, are still ambiguous. We hypothesized that osteoblast-specific cell-surface molecules could contribute to the fine modulation of bone remodeling.

Therefore, we searched for regulatory cell-surface molecules expressed on osteoblasts by utilizing B-cell hybridoma technology. BALB/c mice were immunized with a clone of the rat osteoblastic cell line ROS17/2.8 and a panel of antibodies was prepared by fusing splenocytes with murine myeloma cell line (P3X63-AG8-U1). After screening and extensive cloning, one hybridoma secreting the monoclonal antibody-A7 (A7 MAb) highly specific to cells in the osteoblast lineage was obtained. Immunoreactivity of A7 MAb was examined using cultures of osteoblasts and bone marrow cultures and by use of bone tissue sections. Bioactivity of this MAb was assessed using in vitro calcification system of primary calvarial-

(3)

derived osteoblasts and bone marrow cultures for forming osteoclasts. Immunoreactivity of A7 MAb was also examined in mandibles of adult and neonatal rats.

In vitro, A7 antigen was expressed on cell-surface of osteoblasts and osteoblast-like bone marrow stromal cells. In vivo, A7 antigen was detected in a subset of bone surface osteoblasts and in osteocytes, with a typical cell membrane expression pattern. Tissue array analysis showed a limited expression of A7 antigen in osteocytes just close to the bone surface. Immunoblotting revealed that A7 antigen was lineage-specific of approximate molecular weight of 45 KDa. Immunoprecipitation of A7 antigen from biotinylated osteoblast cell-surface proteins also gave a single band of 45 KDa protein. Cross-linking of cell-surface A7 antigen in cultures of osteoclastogenesis showed limited stimulation of osteoclast formation. Marked suppression of calcification in primary osteoblast cultures was observed when A7 antigen was cross-linked with A7 MAb.

A7 antigen was also expressed in mature odontoblasts. These data collecively suggest that A7 antigen could regulate recruitment of osteoclasts and triggering of calcification. A7 antigen could be an important molecule involved in the fine regulation of bone remodeling. The expression of A7 antigen in odontoblasts also suggests a regulatory role of this antigen in odontoblast differentiation and dentin regeneration.

参照

関連したドキュメント

Character- ization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. IGFBP-4 is an inhibitor of canonical Wnt signalling

performed 4 h and 8 h euglycemic (5.5 mmol/l) clamps with 3 different insulin concentrations (basal, medium postprandial and high postprandial, ranging from ~ 35 to ~ 1450 pmol/l)

Since SgIGSF in the liver and lung is present on the apposing membranes of the same cell types, it is likely to be involved primarily in the homophilic binding, although

Intensification Therapy with Anti-Parathyroid Hormone-related Protein Antibody Plus Zoledronic Acid for Bone Metastases of Small Cell Lung Cancer Cells in SCID Mice.. Tadaaki

Consistent with the results of echocardiographic and histo- logical measurement, the mRNA expression levels of these cardiac remodeling markers were significantly decreased

This review describes the properties of acidic oligopeptides and introduces the tagging of three model drugs, estradiol, quinolone antibiotics, and tissue-non-specific

Design of a radiopharmaceutical for the palliation of painful bone metastases: rhenium-186-labeled bisphosphonate

These findings further suggest that CD45 + /ColI + may contribute to kidney fibrosis by producing MCP-1/CCL2 and TGF-beta, which may be responsible for chronic